A vast majority of people overestimate the life-saving benefits of breast and prostate cancer screening, according to a new study published online August 12 in the Journal of the National Cancer Institute.
Gerd Gigerenzer, of the Max Planck Institute for Human Development in Berlin, and colleagues conducted a survey of over 10,200 people from nine European countries to assess perceptions of cancer-specific mortality reduction associated with mammography and prostate-specific antigen screening, and to determine the sources of information they rely on.
Breast Cancer during Pregnancy
Management of breast cancer during pregnancy or pregnancy associated breast cancer requires special consideration to avoid harm to the fetus.
Advertisement
The authors found that the majority of participants have a dramatic overestimation of the benefits of such tests, and that doctors and other sources of information appear to have little impact on improving knowledge of the level of benefit. Ninety-two percent of women overestimated the benefit of mammography screening by at least one order of magnitude or reported they did not know; 89% of men overestimated the benefit of prostate-specific antigen screening or did not know.
"Knowing the benefit of a treatment is a necessary condition for informed consent and rational decision making," the authors write.
In an accompanying editorial, Lisa M. Schwartz, M.D., and Steven Woloshin, M.D. of the Dartmouth Institute for Health Policy & Clinical Practice in Hanover, N.H., point out that accurate screening messages should be more prominent and include risks associated with overdiagnosis and overtreatment.
![Cervical Cancer - Incidence]( "Cervical Cancer - Incidence")
Cervical cancer is the second most common cancer among women and is the primary cause of cancer-related deaths in developing countries
The editorialists call some of the researchers' methods biased toward overestimation and question if participants are truly representative of the European Union, but do acknowledge the study's contribution. "These cautions...do not diminish the importance of the study...," they write. "We need to move from selling screening to helping people realize that screening is a genuine choice..."
Source: Eurekalert
RAS
In an accompanying editorial, Lisa M. Schwartz, M.D., and Steven Woloshin, M.D. of the Dartmouth Institute for Health Policy & Clinical Practice in Hanover, N.H., point out that accurate screening messages should be more prominent and include risks associated with overdiagnosis and overtreatment.
Cervical Cancer - Incidence
Cervical cancer is the second most common cancer among women and is the primary cause of cancer-related deaths in developing countries
Advertisement
The editorialists call some of the researchers' methods biased toward overestimation and question if participants are truly representative of the European Union, but do acknowledge the study's contribution. "These cautions...do not diminish the importance of the study...," they write. "We need to move from selling screening to helping people realize that screening is a genuine choice..."
Source: Eurekalert
RAS
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.